Skip to main content
Log in

Is LV dysfunction screening in childhood cancer survivors cost effective?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ehrhardt MJ, et al. Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer. Journal of Clinical Oncology : JCO2000418, 14 Aug 2020. Available from: URL: http://doi.org/10.1200/JCO.20.00418

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Is LV dysfunction screening in childhood cancer survivors cost effective?. PharmacoEcon Outcomes News 861, 22 (2020). https://doi.org/10.1007/s40274-020-7104-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7104-y

Navigation